Gamma vaccines has entered a collaboration agreement with Capricorn Technologies GmBH (Austria) and Aptum Adjuvants Ltd (UK) to investigate and develop vaccines that marry Gamma Vaccines manufacturing technology with Capricorn’s novel vaccines and Aptum’s innovative approach to increasing vaccine effectiveness.
18/03/2025
Gamma Vaccines Changes its Status to a Public Company Limited by Shares
Gamma Vaccines announces that it has changed its status from a Private Company limited by shares to a…